Tag debug info: client: {"assets":{},"datasets":{},"live":{},"projects":{},"users":{},"observable":{"assets":{},"datasets":{},"live":{},"projects":{},"users":{}}} Now: 1770493299917 Cache Key: cqdTagPageBySlug:breast-cancer fetchCache[cqdTagPageBySlug:breast-cancer].expirationTime: 1770493288949 fetchCache[cqdTagPageBySlug:breast-cancer]. seconds remaining: -10.968 All fetchCache expiration times: -- Key: cqdNotFoundPage, seconds remaining: 2535 -- Key: cqdTagPageBySlug:breast-cancer, seconds remaining: -10968 -- Key: cqdPostsByTag:cqd-migrated-tag-131,5,10, seconds remaining: -10874 -- Key: cqdTagPageBySlug:sangeeta-kashyap, seconds remaining: -7300 -- Key: cqdPostsByTag:cqd-migrated-tag-1472,2,10, seconds remaining: -7226 -- Key: cqdTagPageBySlug:nephrologists-transforming-dialysis-safety-ntds, seconds remaining: -6986 -- Key: cqdPostsByTag:cqd-migrated-tag-12507,1,10, seconds remaining: -6898 -- Key: cqdTagPageBySlug:total-hip-arthroplasty-tha, seconds remaining: -3199 -- Key: cqdPostsByTag:cqd-migrated-tag-2928,3,10, seconds remaining: -3153 -- Key: cqdTagPageBySlug:living-donor-liver-transplantation, seconds remaining: 2535 -- Key: cqdPostsByTag:cqd-migrated-tag-25752,1,10, seconds remaining: 2616 -- Key: cqdTagPageBySlug:community-health, seconds remaining: 5540 -- Key: cqdPostsByTag:cqd-migrated-tag-19485,2,10, seconds remaining: 5620 -- Key: cqdTagPageBySlug:pelin-batur, seconds remaining: 6996 -- Key: cqdPostsByTag:cqd-migrated-tag-4436,1,10, seconds remaining: 7079 -- Key: cqdTagPageBySlug:steven-nissen, seconds remaining: 8302 -- Key: cqdPostsByTag:cqd-migrated-tag-197,1,10, seconds remaining: 8376 conditions: -- true, -- true, -- true, -- false -- false Cache miss for key cqdTagPageBySlug:breast-cancer - retrieving from Sanity CCCache.dataFetchCount: 14122 Cache cleanup seconds remaining: 9032
Advertisement
Advertisement
Cleveland Clinic study finds it’s safe and effective
Will we see this major breakthrough in 2019?
Similar outcomes at lower cost than hypofractionated whole breast irradiation
Understanding resistance in PARP inhibitor therapy
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Multigene panel testing valuable regardless of age, cancer history
Increased invasive disease-free survival, disease-free survival and overall survival
10-year outcomes favor autologous over implant
Trial may lead to first FDA approval in this realm
Fat necrosis is a benign but real concern
Phase 1b trial shows good response rate
Rendered: Sat Feb 07 2026 19:41:40 GMT+0000 (Coordinated Universal Time)
9500 Euclid Avenue, Cleveland, Ohio 44195 |
800.223.2273 | ©
2026 Cleveland Clinic. All Rights Reserved.